Progress of chimeric antigen receptor T-cell therapy in treatment of hematological malignancies / 白血病·淋巴瘤

ABSTRACT

Chimeric antigen receptor T-cell (CAR-T) therapy is effective in treating lymphoma and leukemia. A large number of basic and clinical studies have led to the rapid development of CAR-T therapy. This paper reviews the concept of CAR-T therapy, the application of CAR-T in hematologic diseases, and the problems and solutions of CAR-T.